治疗癌症的神奇药物——距离我们还有多远？ - Suppr

Suppr

超能文献

A magic bullet for cancer--how near and how far?

作者信息

Schnipper L E, Strom T B

出版信息

N Engl J Med. 2001 Jul 26;345(4):283-4. doi: 10.1056/NEJM200107263450409.

DOI:10.1056/NEJM200107263450409

PMID:11474668

Abstract

摘要

相似文献

A magic bullet for cancer--how near and how far?

N Engl J Med. 2001 Jul 26;345(4):283-4. doi: 10.1056/NEJM200107263450409.

Treatment of hairy-cell leukemia.

N Engl J Med. 2001 Nov 15;345(20):1500-1. doi: 10.1056/NEJM200111153452015.

First responses seen in cancer patients to a recombinant immunotoxin.

J Natl Cancer Inst. 1999 Dec 1;91(23):1997. doi: 10.1093/jnci/91.23.1997.

Immunobiological treatments of hairy-cell leukaemia.

Best Pract Res Clin Haematol. 2003 Mar;16(1):117-33. doi: 10.1016/s1521-6926(03)00003-3.

Serotherapy of cancer.

Semin Oncol. 1989 Jun;16(3):180-98.

Drug-conjugated monoclonal antibodies for the treatment of cancer.

Curr Opin Pharmacol. 2005 Oct;5(5):543-9. doi: 10.1016/j.coph.2005.04.017.

Lymphoma, hairy-cell leukemia respond to new agents.

Oncology (Williston Park). 1992 Sep;6(9):94.

Rituximab in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine (SAKK 31/98).

Haematologica. 2008 Sep;93(9):1426-8. doi: 10.3324/haematol.11564. Epub 2008 Jul 4.

[Protein engineering of Pseudomonas exotoxin and its targeting therapy of cancer].

Tanpakushitsu Kakusan Koso. 1989 Oct;34(13):1793-803.

Monoclonal antibody therapy of cancer.

Semin Oncol. 1999 Oct;26(5 Suppl 14):43-51.

引用本文的文献

Reviving the guardian of the genome: Small molecule activators of p53.

Pharmacol Ther. 2017 Oct;178:92-108. doi: 10.1016/j.pharmthera.2017.03.013. Epub 2017 Mar 27.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

A magic bullet for cancer--how near and how far?

N Engl J Med. 2001 Jul 26;345(4):283-4. doi: 10.1056/NEJM200107263450409.

Treatment of hairy-cell leukemia.

N Engl J Med. 2001 Nov 15;345(20):1500-1. doi: 10.1056/NEJM200111153452015.

First responses seen in cancer patients to a recombinant immunotoxin.

J Natl Cancer Inst. 1999 Dec 1;91(23):1997. doi: 10.1093/jnci/91.23.1997.

Immunobiological treatments of hairy-cell leukaemia.

Best Pract Res Clin Haematol. 2003 Mar;16(1):117-33. doi: 10.1016/s1521-6926(03)00003-3.

Serotherapy of cancer.

Semin Oncol. 1989 Jun;16(3):180-98.

Drug-conjugated monoclonal antibodies for the treatment of cancer.

Curr Opin Pharmacol. 2005 Oct;5(5):543-9. doi: 10.1016/j.coph.2005.04.017.

Lymphoma, hairy-cell leukemia respond to new agents.

Oncology (Williston Park). 1992 Sep;6(9):94.

Rituximab in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine (SAKK 31/98).

Haematologica. 2008 Sep;93(9):1426-8. doi: 10.3324/haematol.11564. Epub 2008 Jul 4.

[Protein engineering of Pseudomonas exotoxin and its targeting therapy of cancer].

Tanpakushitsu Kakusan Koso. 1989 Oct;34(13):1793-803.

Monoclonal antibody therapy of cancer.

Semin Oncol. 1999 Oct;26(5 Suppl 14):43-51.

引用本文的文献

Reviving the guardian of the genome: Small molecule activators of p53.

Pharmacol Ther. 2017 Oct;178:92-108. doi: 10.1016/j.pharmthera.2017.03.013. Epub 2017 Mar 27.